Abstract:DNA-binding molecules that recognize specific sequences offer a high potential for the understanding of chromatin structure and associated biological processes in addition to their therapeutic potential, e.g. as positioning agents for validated anticancer drugs. A prerequisite for the development of DNA-binding molecules is the availability of appropriate methods to assess their binding properties quantitatively at the desired target sequence in the human genome. We have further developed a capture assay to assess triplex-forming oligonucleotide (TFO) binding efficiency quantitatively. This assay is based on bifunctional, psoralen and biotin-conjugated, TFOs and real-time PCR analysis. We have applied this novel quantification method to address two issues that are relevant for DNA-binding molecules. First, we have compared directly the extent of TFO-binding in three experimental settings with increasing similarity to the situation in vivo, i.e. naked genomic DNA, isolated cell nuclei, or whole cells. This comparison allows us to characterize factors that influence genomic triplex formation, e.g. chromosomal DNA organization or intracellular milieu. In isolated nuclei, the binding was threefold lower compared to naked DNA, consistent with a decreased target accessibility int he nucleosomal environment. Binding was detected in whole cells, indicating that the TFO enters the nucleus and binds to its target in intact cells in vivo, but the efficiency was decreased (tenfold) compared to nuclei. Secondly, we applied the method to characterize the binding properties of two different TFOs targeting the same sequence. We found that an antiparallel-binding GT-containing TFO bound more efficiently, but with less target sequence selectivity compared to a parallel-binding CU-containing TFO. Collectively, a sensitive method to characterize genomic triplex formation was described. This may be useful for the determination of factors driving TFO binding efficiency and, thus, may improve the usefulness of triplex-mediated gene targeting for studies of chromatin structure as well as for therapeutic antigene strategies.

Application of Artificially Induced Double-strand Breaks （DSB） and Triplex-forming Oligonucleotides （TFO） in the Improvement of Gene Targeting Efficiency

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Gene targeting and its application

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

Research of Ultrasound-Mediated Gene Delivery

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Recent advances in targeted genome engineering in mammalian systems.

Targeted Gene Correction Directed by Chimeric RNA/DNA Oligonucleotides

Two-in-one Combination Therapy of Fluoronucleoside Analogues and Triplex Forming Oligonucleotides

Target Binding and Residence: a New Determinant of DNA Double-Strand Break Repair Pathway Choice in CRISPR/Cas9 Genome Editing

Cell death caused by single-stranded oligodeoxynucleotide-mediated targeted genomic sequence modification.

Precise Gene Knock‐In Tools with Minimized Risk of DSBs: A Trend for Gene Manipulation

Progress in zinc finger nuclease engineering for targeted genome modification]

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Gene Targeting Facilitated by Engineered Sequence-Specific Nucleases: Potential Applications for Crop Improvement.

An Efficient and Multiple Target Transgenic RNAi Technique with Low Toxicity in Drosophila

A Highly Efficient Site-Specific Integration Strategy Using Combination of Homologous Recombination and the ΦC31 Integrase.

Precise Gene Modification Mediated by TALEN and Single-Stranded Oligodeoxynucleotides in Human Cells.

Characterization and quantification of triple helix formation in chromosomal DNA